中文名稱:阿拉氯胺 | 英文名稱:Alagebrium chloride |
CAS:341028-37-3 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.65% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T7143 |
名稱 | Alagebrium chloride |
描述 | Alagebrium chloride (ALT711) is an advanced glycation end product (AGE) inhibitor, and has proven effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic |
動(dòng)物實(shí)驗(yàn) | Rat aortic vascular smooth muscle cells (RASMCs) were treated with 1-100 μM of alagebrium added 24 hours before the addition of AGEs.?This in vivo study was done using 8-week-old male rats that were injected intraperitoneally with 80 mg/kg STZ.?Sixteen weeks later, the diabetic rats were treated with 10 mg/kg alagebrium for 4 weeks, after which carotid artery balloon injury was induced.?After 4 weeks, the animals were sacrificed for histological analysis[1]. |
體內(nèi)活性 | 在糖尿病大鼠中,Alagebrium處理顯著抑制了頸動(dòng)脈氣球損傷后的新生內(nèi)膜增生,這種效果是由于其抑制細(xì)胞內(nèi)ROS合成,進(jìn)而導(dǎo)致RASMCs增殖受到抑制[1]。 |
存儲(chǔ)條件 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 65 mg/mL (242.75 mM), Sonication is recommended. |
關(guān)鍵字 | Alagebrium chloride | Endogenous Metabolite | ALT-711 | Inhibitor | inhibit | Alagebrium | Alagebrium Chloride | ALT 711 |
相關(guān)產(chǎn)品 | Glycerol | Sucrose | Ferulic Acid | Thymidine |
相關(guān)庫 | 抑制劑庫 | 經(jīng)典已知活性庫 | 已知活性化合物庫 | 抗糖尿病庫 | 抗高血壓化合物庫 | 臨床期小分子藥物庫 | 藥物功能重定位化合物庫 |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP3年
|
河南威梯?;た萍加邢薰?/div>
|
2024-11-18 | |
詢價(jià) |
VIP1年
|
上海和寧美生物醫(yī)藥科技有限公司
|
2024-10-28 | |
詢價(jià) |
VIP11年
|
上海升德醫(yī)藥科技有限公司
|
2024-10-22 | |
¥107.90 |
VIP1年
|
上海阿拉丁生化科技股份有限公司
|
2024-08-16 |